Lineage Cell Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.00
|
|
Average Rating
|
4.43
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.04
|
-0.04
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.04
|
-0.04
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.03
|
-0.04
|
-0.01
|
-33.33%
|
|
2021-12-31
|
-0.05
|
-0.17
|
-0.12
|
-240.00%
|
|
2021-09-30
|
-0.05
|
-0.05
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.04
|
-0.03
|
0.01
|
25.00%
|
|
2021-03-31
|
-0.04
|
-0.01
|
0.03
|
75.00%
|
|
2020-12-31
|
-0.05
|
0.01
|
0.06
|
120.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.12
|
|
2021-12-31
|
-0.26
|
|
2020-12-31
|
-0.14
|
|
2019-12-31
|
-0.04
|
|
2018-12-31
|
-0.32
|
|
2017-12-31
|
-0.11
|
|
2016-12-31
|
0.32
|
|
2015-12-31
|
-0.59
|
|
2014-12-31
|
-0.55
|
|
2013-12-31
|
-0.80
|
|
2012-12-31
|
-0.43
|
|
2011-12-31
|
-0.35
|
|
2010-12-31
|
-0.27
|
|
2009-12-31
|
-0.17
|
|
2008-12-31
|
-0.52
|
|
2003-12-31
|
-0.12
|
|
2002-12-31
|
-0.24
|
|
2001-12-31
|
-1.36
|
|
1997-12-31
|
-0.21
|
|
1996-12-31
|
-0.07
|